Market LIVE
Published markets; coverage varies by country
Product profile · United States

RAYALDEE

 ·  Patent Litigation & Settlement History ↓

IngredientCALCIFEDIOL
Application typeNDA
Application208010
Product001
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Strength0.03MG
Approval date2016-06-17
Marketing statusPrescription
Status event—
ApplicantEIRGEN
Product source

Current GenericRadar decision

Year2028
SelectionDEEP_REVIEW
ReviewFINAL_CHECKING
Anchor typeDS_EQUIVALENT
Anchor date2028-08-27
Patent anchor2028-08-27
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2028. Anchor type: DS_EQUIVALENT. Patent anchor: 2028-08-27. Exclusivity anchor: not recorded. Anchor date: 2028-08-27. Patent tail: yes. Exclusivity tail: no. Review status: FINAL_CHECKING. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
102134422027-02-02DP ————
———
89064102027-02-02DP ————
———
99435302027-02-02U U-2274———
———
111545092028-04-25U U-3815———
———
82071492028-04-25U U-1871———
———
87783732028-04-25U U-1873———
———
94088582028-04-25U U-1888———
———
94984862028-04-25U U-3814———
———
99251472028-04-25DP/U U-2256———
———
99251472028-04-25DP/U U-2255———
———
99251472028-04-25DP/U U-2259———
———
99251472028-04-25DP/U U-2258———
———
99251472028-04-25DP/U U-2257———
———
83614882028-07-19DP ————
———
84263912028-08-27U U-1872———
———
118012532030-09-07DP/U U-3722———
———
118012532030-09-07DP/U U-3723———
———
118012532030-09-07DP/U U-3721———
———
103000782034-03-14DP ————
———
103575022034-03-14DP ————
———
112535282034-03-14DP ————
———
98616442034-03-14DP ————
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.